Skip to content
Back to browse
BRAIN Publication-derived

Huntington's Disease Cortical Organoids

Source Galimberti et al., 2024 · University of Milan, Department of Biosciences · 10.1038/s41467-024-50877-x

Authors: Maura Galimberti, Maria R. Nucera, Vittoria D. Bocchi, Paola Conforti, Elena Vezzoli, Matteo Cereda, Camilla Maffezzini, Raffaele Iennaco, Andrea Scolz, Andrea Falqui, Chiara Cordiglieri, Martina Cremona, Ira Espuny-Camacho, Andrea Faedo, Dan P. Felsenfeld, Thomas F. Vogt, Valeria Ranzani, Chiara Zuccato, Dario Besusso, Elena Cattaneo Duration: 120 days 5 phases Cell source: Human ESC (RUES2)

Abstract

This protocol describes the generation of three-dimensional telencephalic organoids from isogenic human ESC lines (RUES2) that recapitulate ventral and dorsal telencephalic identities. The protocol enables the study of neurodevelopmental alterations and cell-autonomous and non-cell autonomous mechanisms in Huntington's disease by allowing co-culture of healthy and disease-bearing cells within a single organoid.

Cell source
Human ESC (RUES2)
Application
Disease modeling - Huntington's disease

Protocol overview

15 steps across 5 phases

Phase 1 · hESC maintenance and preparation Before Day 0
  1. a Culture human ESCs on Geltrex-coated plates
  2. b Prepare cells for organoid aggregation
  3. c Seed cells in V-bottom 96-well plate
Phase 2 · Neural induction Day 2 - Day 6
  1. a Replace medium with Neural Induction Medium
  2. b Perform partial medium changes
Phase 3 · Ventral/dorsal patterning Day 6 - Day 18
  1. a Add morphogens for ventral patterning
  2. b Continue partial medium changes during patterning
Phase 4 · Embedding and maturation Day 18 - Day 120
  1. a Transfer organoids to 6 cm² dish on orbital shaker
  2. b Embed organoids in Geltrex matrix
  3. c Switch to Neuronal Differentiation Medium
  4. d Perform partial medium changes during maturation
  5. e Continue culture until Day 120
Phase 5 · Mosaic organoid generation (optional - for co-culture studies) Before Day 0 - Day 120
  1. a Generate stable GFP and TOMATO-expressing cell lines via lentiviral transduction
  2. b Co-aggregate CTRL and HD cells at 1:1 ratio
  3. c Harvest mosaic organoids at Day 120 and FACS sort

Full SOP

Full SOPs need an account and a plan

Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.

Create an account

Already registered? Log in

Attribution

This SOP was written by Organthis based on the published method in Galimberti et al., 2024. Once the originating laboratory has confirmed it, the SOP is marked Verified.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.